Clinical Trials Directory

Trials / Completed

CompletedNCT03908697

Quantum Natural Family Planning Pilot

Comparison of Two Hormonal Fertility Monitors for Use in Natural Family Planning

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
26 (actual)
Sponsor
Quanovate Tech Inc. · Industry
Sex
Female
Age
18 Years – 42 Years
Healthy volunteers
Accepted

Summary

•The Pilot study will involve current Marquette Method users who own and use a ClearBlue Fertility monitor and who will be asked to simultaneously use the Mira monitor for the sake of comparing the two devices to monitor the menstrual cycle.

Detailed description

* The Mira fertility monitoring system (www.miracare.com) is a new home-use hormone tracking device with the ability to quantitatively measure reproductive hormones in the urine but is also synced to a smart phone App that provides a graphic representation of the hormonal levels throughout a menstrual cycle. * The Mira monitor will be compared to the ClearBlue Fertility Monitor for its ease of use, satisfaction, and accuracy. * The Mira hormonal monitor and App system has not been tested for its use in Natural Family Planning (NFP). * The Pilot study will involve current Marquette Method users who own and use a ClearBlue Fertility monitor and who will be asked to simultaneously use the Mira monitor for the sake of comparing the two devices. * Female participants invited to participate will need to meet the following criteria: * Age 18 to 42 years * Menstrual cycle ranging between 21-42 days * At least 3 cycles after cessation of breastfeeding * Not currently on medications that affect ovulation and 3 months prior * Not currently pregnant or breastfeeding * No known fertility problems * Not planning on achieving pregnancy during the 3 menstrual cycles of the study

Conditions

Interventions

TypeNameDescription
DEVICEMira monitor comparison to ClearBlue monitorTesting first morning urine with hormone test sticks at home

Timeline

Start date
2020-05-29
Primary completion
2021-02-28
Completion
2021-04-22
First posted
2019-04-09
Last updated
2025-03-24

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03908697. Inclusion in this directory is not an endorsement.